Protalix Biotherapeutics Inc. (PBDA)
Market Closed
24 Feb, 20:00
XFRA 
€
2. 54
-0.08
-3.05%
€
- Market Cap
12.78 P/E Ratio
- Div Yield
0 Volume
0.21 Eps
€ 2.62
Previous Close Day Range
2.54 2.62
Year Range
1.14 2.7
Want to track PBDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PBDA earnings report is expected in 21 days (17 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.01 | - |
| | | 0.06 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PBDA Earnings Reports FAQ
What is the earnings per share (EPS) for PBDA?
The current EPS is 0.21.
What is the company's earnings growth rate?
Protalix Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-17, based on the PBDA's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Protalix Biotherapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PBDA at this time, as Protalix Biotherapeutics Inc has no recent EPS data to calculate it.
